Freestone Capital Holdings’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-20
Closed -$8.06K 462
2020
Q4
$8.06K Buy
+20
New +$6.23K ﹤0.01% 904

Other funds holding BDSX

Freestone Capital Holdings's BDSX Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Biodesix (BDSX) in Q1 2021, closing a stake of 20 shares — an estimated $8.06K sold.

Freestone Capital Holdings first reported a position in BDSX in Q4 2020 and held it in 1 quarter. The position peaked at $8.06K in Q4 2020. 46 funds tracked by Wall St. Rank hold BDSX as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Biodesix position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 20 Biodesix shares in Q1 2021, an estimated $8.06K.
  • Freestone Capital Holdings first reported a position in Biodesix in Q4 2020 and held it in 1 quarter.
  • Freestone Capital Holdings's Biodesix position peaked at $8.06K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held Biodesix as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.